1. Home
  2. REVB vs BOXL Comparison

REVB vs BOXL Comparison

Compare REVB & BOXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REVB
  • BOXL
  • Stock Information
  • Founded
  • REVB 2020
  • BOXL 1985
  • Country
  • REVB United States
  • BOXL United States
  • Employees
  • REVB N/A
  • BOXL N/A
  • Industry
  • REVB Biotechnology: Pharmaceutical Preparations
  • BOXL Telecommunications Equipment
  • Sector
  • REVB Health Care
  • BOXL Telecommunications
  • Exchange
  • REVB Nasdaq
  • BOXL Nasdaq
  • Market Cap
  • REVB 2.8M
  • BOXL 3.3M
  • IPO Year
  • REVB N/A
  • BOXL 2017
  • Fundamental
  • Price
  • REVB $2.92
  • BOXL $1.55
  • Analyst Decision
  • REVB
  • BOXL Buy
  • Analyst Count
  • REVB 0
  • BOXL 3
  • Target Price
  • REVB N/A
  • BOXL $5.00
  • AVG Volume (30 Days)
  • REVB 147.3K
  • BOXL 25.8K
  • Earning Date
  • REVB 05-09-2025
  • BOXL 05-07-2025
  • Dividend Yield
  • REVB N/A
  • BOXL N/A
  • EPS Growth
  • REVB N/A
  • BOXL N/A
  • EPS
  • REVB N/A
  • BOXL N/A
  • Revenue
  • REVB N/A
  • BOXL $135,893,000.00
  • Revenue This Year
  • REVB N/A
  • BOXL $3.88
  • Revenue Next Year
  • REVB N/A
  • BOXL N/A
  • P/E Ratio
  • REVB N/A
  • BOXL N/A
  • Revenue Growth
  • REVB N/A
  • BOXL N/A
  • 52 Week Low
  • REVB $2.36
  • BOXL $1.06
  • 52 Week High
  • REVB $60.80
  • BOXL $10.65
  • Technical
  • Relative Strength Index (RSI)
  • REVB 45.77
  • BOXL 50.88
  • Support Level
  • REVB $2.76
  • BOXL $1.44
  • Resistance Level
  • REVB $3.62
  • BOXL $1.61
  • Average True Range (ATR)
  • REVB 0.41
  • BOXL 0.17
  • MACD
  • REVB 0.02
  • BOXL 0.05
  • Stochastic Oscillator
  • REVB 34.12
  • BOXL 82.91

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells and services interactive solutions predominantly for the education market, but also for the corporates and government sectors. The company currently designs, produces and distributes interactive technologies including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls and digital signage. The company also distributes science, technology, engineering and math (or STEM) products, including 3D printing and robotics solutions, and a portable science lab.

Share on Social Networks: